Table 3. Relationship between serum visfatin levels and clinical factors in HCC patients.
| Characteristics | Low Visfatin level | High Visfatin level | χ2 | P |
|---|---|---|---|---|
| (n=81) | (n=54) | |||
| Age | 0.028 | 0.867 | ||
| <60 | 62(76.5) | 42(77.8) | ||
| >60 | 19(23.5) | 12(22.2) | ||
| Gender | 4.049 | 0.044 | ||
| Man | 67(82.7) | 51(94.4) | ||
| Female | 14(17.3) | 3(5.6) | ||
| Smoking | 4.256 | 0.039 | ||
| Yes | 30(37.0) | 11(20.4) | ||
| No | 51(63.0) | 43(79.6) | ||
| Drinking | 0.092 | 0.761 | ||
| Yes | 26(32.1) | 16(29.6) | ||
| No | 55(67.9) | 38(70.4) | ||
| Tumor size | 10.709 | 0.001 | ||
| <3cm | 56(69.1) | 22(40.7) | ||
| ≥3cm | 25(30.9) | 32(59.3) | ||
| Tumor stage | 6.058 | 0.014 | ||
| I, II | 49(60.5) | 21(38.9) | ||
| III, IV | 32(39.5) | 33(61.1) | ||
| 5 years survival | 3.913 | 0.048 | ||
| Dead | 65(80.2) | 50(92.6) | ||
| Alive | 16(19.8) | 4(7.4) |